4//SEC Filing
Deshpande Milind 4
Accession 0000899243-21-000690
CIK 0001701108other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:27 PM ET
Size
5.8 KB
Accession
0000899243-21-000690
Insider Transaction Report
Form 4
Deshpande Milind
Director
Transactions
- Award
Stock Option (right to buy)
2021-01-04$13.31/sh+2,629$34,992→ 2,629 totalExercise: $17.93Exp: 2031-01-04→ Common Stock (2,629 underlying)
Footnotes (2)
- [F1]This stock option shall vest in four quarterly installments on the last day of each calendar quarter during the calendar year subject to the Reporting Person's continued service as a non-employee director.
- [F2]This stock option was issued to the Reporting Person, who elected to take stock options in lieu of $35,000 in cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation policy.
Documents
Issuer
Spero Therapeutics, Inc.
CIK 0001701108
Entity typeother
Related Parties
1- filerCIK 0001378588
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:27 PM ET
- Size
- 5.8 KB